Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Jiudian Hongyang Pharmaceutical is a specialized pharmaceutical company focused on the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. As a key subsidiary of the publicly traded Hunan Jiudian Pharmaceutical, the company operates high-standard manufacturing facilities that comply with national GMP requirements. Its product portfolio primarily includes anti-infectives, anti-diabetics, and anti-inflammatory agents, with notable products such as Ornidazole, Tinidazole, and Gliclazide. The company serves as a critical production base for its parent organization while also supplying raw materials to the broader domestic and international pharmaceutical markets. Jiudian Hongyang is recognized for its expertise in complex chemical synthesis and high-barrier API development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Jiudian Hongyang Pharmaceutical.